Treatment of refractory chronic graft-versus-host disease with Imatinib: a single center experience

被引:0
|
作者
Carrillo Checa, Javier [1 ]
Rivera Delgado, Daniel Esteban [1 ]
Avendano Pita, Alejandro [1 ]
Presa Morales, Daniel [1 ]
Sobejano Fuertes, Eduardo [1 ]
Higuero Saavedra, Victor [1 ]
Arratibel Zalacain, Nerea [1 ]
Baile Gonzalez, Monica [1 ]
Veiga Vaz, Alvaro [1 ]
Lopez Cadenas, Felix [1 ]
Martin Lopez, Ana A. [1 ]
Perez Lopez, Estefania [1 ]
Cabrero Calvo, Monica [1 ]
Vazquez Lopez, Lourdes [1 ]
Sanchez Guijo, Fermin [1 ]
Caballero Barrigon, Maria Dolores [1 ]
Lopez Corral, Lucia [1 ]
机构
[1] Complejo Asistencial Univ Salamanca IBSAL, Hematol, Salamanca, Spain
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P420
引用
收藏
页码:460 / 461
页数:2
相关论文
共 50 条
  • [1] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Ferreira, Aliana Meneses
    Pontes da Silva, Carolina Atallah
    Pereira, Andre Domingues
    Szor, Roberta Shcolnik
    Brito Medeiros da Fonseca, Ana Rita
    Serpa, Mariana Gomes
    Xavier, Erick Menezes
    Sampaio de Melo, Michelly Kerly
    Novis, Yana
    Tucunduva, Luciana
    Rocha, Vanderson
    Arrais-Rodrigues, Celso
    BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 503 - 506
  • [2] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Aliana Meneses Ferreira
    Carolina Atallah Pontes da Silva
    André Domingues Pereira
    Roberta Shcolnik Szor
    Ana Rita Brito Medeiros da Fonseca
    Mariana Gomes Serpa
    Erick Menezes Xavier
    Michelly Kerly Sampaio de Melo
    Yana Novis
    Luciana Tucunduva
    Vanderson Rocha
    Celso Arrais-Rodrigues
    Bone Marrow Transplantation, 2018, 53 : 503 - 506
  • [3] Efficacy of Imatinib Mesylate in the Treatment of Refractory Sclerodermatous Chronic Graft-Versus-Host Disease
    Yakoub-Agha, Ibrahim
    Magro, Leonardo
    Catteau, Benoit
    Willekens, Christophe
    Coiteux, Valerie
    Bruno, Benedicte
    Terriou, Louis
    Jouet, Jean-Pierre
    BLOOD, 2008, 112 (11) : 745 - 746
  • [4] Imatinib for refractory chronic graft-versus-host disease with fibrotic features
    Olivieri, Attilio
    Locatelli, Franco
    Zecca, Marco
    Sanna, Adele
    Cimminiello, Michele
    Raimondi, Roberto
    Gini, Guido
    Mordini, Nicola
    Balduzzi, Adriana
    Leoni, Pietro
    Gabrielli, Armando
    Bacigalupo, Andrea
    BLOOD, 2009, 114 (03) : 709 - 718
  • [5] Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
    Chin, Kuo-Kai
    Kim, Haesook T.
    Inyang, Eno-Abasi
    Ho, Vincent
    Koreth, John
    Romee, Rizwan
    Gooptu, Mahasweta
    Shapiro, Roman
    Antin, Joseph
    Soiffer, Robert
    Jaglowski, Samantha
    Pidala, Joseph
    Cutler, Corey
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 990.e1 - 990.e7
  • [6] Imatinib mesylate in the treatment of sclerodermatous chronic graft-versus-host disease
    Yakoub-Agha, I.
    Magro, L.
    Catteau, B.
    Coiteux, V.
    Terriou, L.
    Jouet, J. P.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S190 - S190
  • [7] Belumosudil for the treatment of chronic graft-versus-host disease: a single center real-world experience
    Modi, Badri
    Ngo, Dat
    Chen, Jason
    Yang, Dongyun
    Shan, Haoyue
    Sandhu, Karamjeet
    Rashid, Nahid
    Amanam, Idoroenyi
    Otoukesh, Salman
    Nakamura, Ryotaro
    Ali, Haris
    Salhotra, Amandeep
    BONE MARROW TRANSPLANTATION, 2025, 60 (04) : 555 - 557
  • [8] Ruxolitinib in the treatment of corticosteroid-refractory graft-versus-host Disease (GVHD). One Single Center Experience
    Torres Ochando, Melissa
    Fernandez-Caldas Gonzalez, Paula
    de la Nuez Melian, Haridian
    Acosta Fleitas, Cynthia
    Jimenez Bravo de Laguna, Santiago
    Perera Alvarez, Maria
    Gonzalez Pinedo, Leslie
    Guerra Dominguez, Luisa
    Suarez Cabrera, Alexia
    Gonzalez del Castillo, Luz Maria
    Perez Ortiz, Leonor
    Molero Labarta, Teresa
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 367 - 368
  • [9] Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience
    De Jong, Cornelis N.
    Saes, Lotte
    Klerk, Clara P. W.
    Van der Klift, Marjolein
    Cornelissen, Jan J.
    Broers, Annoek E. C.
    PLOS ONE, 2017, 12 (10):
  • [10] ETANERCEPT FOR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE: A SINGLE CENTER EXPERIENCE
    de Jong, N.
    Saes, L.
    Klerk, C.
    van der Klift, M.
    Cornelissen, J.
    Broers, A.
    HAEMATOLOGICA, 2016, 101 : 631 - 632